首页 正文

Biochemical and biophysical research communications. 2004 Jul 9;319(4):1322-6. doi: 10.1016/j.bbrc.2004.05.116 1959

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens

人类CYP2B6*6(Q172H和K262R)纯合子与标准依非韦伦方案治疗的HIV-1患者中高水平血浆依非韦伦浓度相关 翻译改进

Kiyoto Tsuchiya  1, Hiroyuki Gatanaga, Natsuo Tachikawa, Katsuji Teruya, Yoshimi Kikuchi, Munehiro Yoshino, Takeshi Kuwahara, Takuma Shirasaka, Satoshi Kimura, Shinichi Oka

作者单位 +展开

作者单位

  • 1 AIDS Clinical Center, International Medical Center of Japan, Tokyo 162-8655, Japan.
  • DOI: 10.1016/j.bbrc.2004.05.116 PMID: 15194512

    摘要 Ai翻译

    Efavirenz (EFV) is metabolized by cytochrome P450 2B6 (CYP2B6) in the liver. We analyzed the genotypes of CYP2B6 and their contribution to plasma EFV concentrations in 35 EFV-treated patients in International Medical Center of Japan. The mean plasma EFV concentration of patients with CYP2B6 *6/*6 (Q172H and K262R) (25.4+/-7.5 microM, +/-SD, n = 2) was significantly higher than that of patients with genotypes *6 heterozygote (9.9+/-3.3 microM, n = 10) or without alleles *6 (8.0+/-2.6 microM, n = 23) (p < 0.0001). To confirm our result, we further analyzed nine patients (three with high EFV concentrations and arbitrarily selected six with normal EFV concentrations) treated in Osaka National Hospital, and it resulted that the only three patients with the high concentrations were the *6/*6 holder. EFV dose could be decreased in those patients harboring the genotype to reduce toxicity with compromising potency, representing the first step of the Tailor-Made therapy of HIV-1 infection.

    Keywords:cyp2b6 genotype; efavirenz concentration; hiv-1patients

    Copyright © Biochemical and biophysical research communications. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

    缩写:BIOCHEM BIOPH RES CO

    ISSN:0006-291X

    e-ISSN:1090-2104

    IF/分区:/

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens